FILE | B | Assessing Risks of Changing Sterile Drug Manufacturing Sites - FDA Response to Vendors

FBO DAILY ISSUE OF MAY 22, 2008 FBO #2369
DOCUMENT

B -- Assessing Risks of Changing Sterile Drug Manufacturing Sites - FDA Response to Vendors

Notice Date: 5/20/2008
Notice Type: FDA Response to Vendors
NAICS: 541618 — Other Management Consulting Services
Contracting Office: Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
ZIP Code: 20857-0001
Solicitation Number: FDA-SOL-08-00641a
Response Due: 5/28/2008 10:00:00 AM
Point of Contact: David - Kordel, Fax: 301-827-7151
E-Mail Address: david.kordel@fda.hhs.gov
Small Business Set-Aside: N/A
Web Link: FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=70f2063052f19d7ef15c9ac6c9ea7934&tab=core&_cview=1)
Document(s): FDA Response to Vendors; File Name: FDA Response to Vendors (ResponseFDASOL0800641a.pdf); Link: https://www.fbo.gov//utils/view?id=ba93efc05ea32228f9cf8a9be6069884; Bytes: 19.90 Kb; Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
Record: SN01577355-W 20080522/080520222602-70f2063052f19d7ef15c9ac6c9ea7934 (fbodaily.com)
Source: FedBizOpps Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's FBO Daily Index Page |